Adding to the hypothesis that a procoagulant state extends beyond the risk of venous thromobosis (VT), Hernández et al. reported that increased TF plasma levels and activity in a number of cancers, amongst them breast cancer, was indicative of worse prognosis, but not of VT [48]. This evidence concerns the gene TF and breast cancer.